Sean Mann, CEO of RP1, is a visionary leader that shapes RP1's strategic direction, drawing from a diverse background in B2C and B2B sectors. #RP1 #MetaverseBrowser #SpatialInternet
Replimune Shares Plummet 45% Following FDA Drug Approval Setback Amid Class Action Lawsuit #United_States #San_Francisco #FDA #Replimune #RP1
Replimune Shares Plunge After FDA Setback and Class Action Threat #United_States #San_Francisco #FDA #Replimune #RP1
Replimune Faces Lawsuit After FDA Rejects RP1 Cancer Drug Application #USA #San_Francisco #Hagens_Berman #Replimune #RP1
Replimune Faces Investor Lawsuit Following FDA's Drug Approval Block #United_States #San_Francisco #Replimune #RP1 #FDA_Block